[Managing hypertension in patients with chronic kidney disease - implications of the SPRINT study].

Optimal blood pressure control is a key measure in slowing the progression of kidney disease and reducing the cardiovascular risk in patients with chronic kidney disease, although the target BP remain controversial. The SPRINT (Systolic Blood Pressure Intervention Trial) demonstrated that intensive treatment of hypertension brings a spectacular reduction in the risk of major cardiovascular events and all-cause mortality in older non-diabetic patients at high cardiovascular risk and chronic kidney disease and mild proteinuria.